Cargando…

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy

Aggregated alpha-synuclein (α-synuclein) is the main component of Lewy bodies (LBs), Lewy neurites (LNs), and glial cytoplasmic inclusions (GCIs), which are pathological hallmarks of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Initiating factors that culminate in forming...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonustun, Berkiye, Altay, Melek Firat, Strand, Catherine, Ebanks, Kirsten, Hondhamuni, Geshanthi, Warner, Thomas T., Lashuel, Hilal A., Bandopadhyay, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909017/
https://www.ncbi.nlm.nih.gov/pubmed/35269528
http://dx.doi.org/10.3390/cells11050906
_version_ 1784666009380061184
author Sonustun, Berkiye
Altay, Melek Firat
Strand, Catherine
Ebanks, Kirsten
Hondhamuni, Geshanthi
Warner, Thomas T.
Lashuel, Hilal A.
Bandopadhyay, Rina
author_facet Sonustun, Berkiye
Altay, Melek Firat
Strand, Catherine
Ebanks, Kirsten
Hondhamuni, Geshanthi
Warner, Thomas T.
Lashuel, Hilal A.
Bandopadhyay, Rina
author_sort Sonustun, Berkiye
collection PubMed
description Aggregated alpha-synuclein (α-synuclein) is the main component of Lewy bodies (LBs), Lewy neurites (LNs), and glial cytoplasmic inclusions (GCIs), which are pathological hallmarks of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Initiating factors that culminate in forming LBs/LNs/GCIs remain elusive. Several species of α-synuclein exist, including phosphorylated and nitrated forms. It is unclear which α-synuclein post-translational modifications (PTMs) appear within aggregates throughout disease pathology. Herein we aimed to establish the predominant α-synuclein PTMs in postmortem IPD and MSA pathology using immunohistochemistry. We examined the patterns of three α-synuclein PTMs (pS87, pS129, nY39) simultaneously in pathology-affected regions of 15 IPD cases, 5 MSA cases, and 6 neurologically normal controls. All antibodies recognized LBs, LNs, and GCIs, albeit to a variable extent. pS129 α-synuclein antibody was particularly immunopositive for LNs and synaptic dot-like structures, followed by nY39 α-synuclein antibody. GCIs, neuronal inclusions, and small threads were positive for nY39 α-synuclein in MSA. Quantification of the LB scores revealed that pS129 α-synuclein was the dominant and earliest α-synuclein PTM, followed by nY39 α-synuclein, while lower amounts of pSer87 α-synuclein appeared later in disease progression in PD. These results may have implications for novel biomarker and therapeutic developments.
format Online
Article
Text
id pubmed-8909017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89090172022-03-11 Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy Sonustun, Berkiye Altay, Melek Firat Strand, Catherine Ebanks, Kirsten Hondhamuni, Geshanthi Warner, Thomas T. Lashuel, Hilal A. Bandopadhyay, Rina Cells Article Aggregated alpha-synuclein (α-synuclein) is the main component of Lewy bodies (LBs), Lewy neurites (LNs), and glial cytoplasmic inclusions (GCIs), which are pathological hallmarks of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Initiating factors that culminate in forming LBs/LNs/GCIs remain elusive. Several species of α-synuclein exist, including phosphorylated and nitrated forms. It is unclear which α-synuclein post-translational modifications (PTMs) appear within aggregates throughout disease pathology. Herein we aimed to establish the predominant α-synuclein PTMs in postmortem IPD and MSA pathology using immunohistochemistry. We examined the patterns of three α-synuclein PTMs (pS87, pS129, nY39) simultaneously in pathology-affected regions of 15 IPD cases, 5 MSA cases, and 6 neurologically normal controls. All antibodies recognized LBs, LNs, and GCIs, albeit to a variable extent. pS129 α-synuclein antibody was particularly immunopositive for LNs and synaptic dot-like structures, followed by nY39 α-synuclein antibody. GCIs, neuronal inclusions, and small threads were positive for nY39 α-synuclein in MSA. Quantification of the LB scores revealed that pS129 α-synuclein was the dominant and earliest α-synuclein PTM, followed by nY39 α-synuclein, while lower amounts of pSer87 α-synuclein appeared later in disease progression in PD. These results may have implications for novel biomarker and therapeutic developments. MDPI 2022-03-06 /pmc/articles/PMC8909017/ /pubmed/35269528 http://dx.doi.org/10.3390/cells11050906 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sonustun, Berkiye
Altay, Melek Firat
Strand, Catherine
Ebanks, Kirsten
Hondhamuni, Geshanthi
Warner, Thomas T.
Lashuel, Hilal A.
Bandopadhyay, Rina
Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title_full Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title_fullStr Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title_full_unstemmed Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title_short Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
title_sort pathological relevance of post-translationally modified alpha-synuclein (pser87, pser129, ntyr39) in idiopathic parkinson’s disease and multiple system atrophy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909017/
https://www.ncbi.nlm.nih.gov/pubmed/35269528
http://dx.doi.org/10.3390/cells11050906
work_keys_str_mv AT sonustunberkiye pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT altaymelekfirat pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT strandcatherine pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT ebankskirsten pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT hondhamunigeshanthi pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT warnerthomast pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT lashuelhilala pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy
AT bandopadhyayrina pathologicalrelevanceofposttranslationallymodifiedalphasynucleinpser87pser129ntyr39inidiopathicparkinsonsdiseaseandmultiplesystematrophy